Effects of Berberine Derivate CPU 86017 on IKur Currents and Experimental Atrial Fibrillation

Yi-Qun TANG,Xiang GUO,Chun-Lin CHEN,Yue-Miao YIN,Min-Hui WANG,Shu-Juan SUN,De-Zai DAI
DOI: https://doi.org/10.3724/sp.j.1009.2010.00212
IF: 3.887
2010-01-01
Chinese Journal of Natural Medicines
Abstract:AIM: Compared with azimilide, the present study was designed to observe the anti-atral fibrillation (AF) effects of CPU 86017, a berberine derivative, and explore its possible ion-channel mechanism. METHODS: The effects of CPU 86017 on ultra-rapid delayed rectifier K+ current (IKur) was studied both on guinea pigs atrial cardiomyocytes and human embryonic kidney (HEK) 293 cell line with whole-cell patch clamp technique. Anti-AF action of CPU 86017 (1.25, 2.5 mg·kg-1, ip) was observed in AF model rats induced by acetylcholine (ACh)-CaCl2. RESULTS: CPU 86017 inhibited IKur in a concentration-dependent manner. The IC50 of IKur on atrial myocytes and HEK293 cells was 4.56 and 0.21 μmol·L-1, respectively. On the AF rats, CPU 86017 effectively shortened AF duration, prolonging atrial effective refractory period (AERP) by 38.9% in rats atrial. CONCLUSION: CPU86017 inhibited IKur in a concentration-dependent manner. It was effective in treating AF partly by inhibiting IKur and prolonging AERP.
What problem does this paper attempt to address?